Works matching IS 17568722 AND DT 2023 AND VI 16 AND IP 1
Results: 123
Novel agents and regimens in acute myeloid leukemia: latest updates from 2022 ASH Annual Meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01411-x
- By:
- Publication type:
- Article
Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01410-y
- By:
- Publication type:
- Article
Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01408-6
- By:
- Publication type:
- Article
Retraction Note: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction : LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: SELP Asp603Asn and severe thrombosis in COVID-19 males.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01403-x
- By:
- Publication type:
- Article
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01400-0
- By:
- Publication type:
- Article
Exploiting RIG-I-like receptor pathway for cancer immunotherapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01405-9
- By:
- Publication type:
- Article
Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01404-w
- By:
- Publication type:
- Article
Protein degradation: expanding the toolbox to restrain cancer drug resistance.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01398-5
- By:
- Publication type:
- Article
Novel CD19-specific γ/δ TCR-T cells in relapsed or refractory diffuse large B-cell lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01402-y
- By:
- Publication type:
- Article
How we treat primary immune thrombocytopenia in adults.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01401-z
- By:
- Publication type:
- Article
A pH-dependent anti-CD47 antibody that selectively targets solid tumors and improves therapeutic efficacy and safety.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01399-4
- By:
- Publication type:
- Article
Payload diversification: a key step in the development of antibody–drug conjugates.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-022-01397-y
- By:
- Publication type:
- Article
The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-022-01396-z
- By:
- Publication type:
- Article
Phase separations in oncogenesis, tumor progressions and metastasis: a glance from hallmarks of cancer.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01522-5
- By:
- Publication type:
- Article
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01520-7
- By:
- Publication type:
- Article
Harnessing immunotherapy for brain metastases: insights into tumor–brain microenvironment interactions and emerging treatment modalities.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01518-1
- By:
- Publication type:
- Article
Multiscale protein networks systematically identify aberrant protein interactions and oncogenic regulators in seven cancer types.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01517-2
- By:
- Publication type:
- Article
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01510-9
- By:
- Publication type:
- Article
Considerations for the design of antibody drug conjugates (ADCs) for clinical development: lessons learned.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01519-0
- By:
- Publication type:
- Article
Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01516-3
- By:
- Publication type:
- Article
Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01512-7
- By:
- Publication type:
- Article
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01507-4
- By:
- Publication type:
- Article
Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01514-5
- By:
- Publication type:
- Article
Direct inhibition of dioxygenases TET1 by the rheumatoid arthritis drug auranofin selectively induces cancer cell death in T-ALL.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01513-6
- By:
- Publication type:
- Article
Genitourinary cancers updates: highlights from ASCO 2023.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01511-8
- By:
- Publication type:
- Article
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01508-3
- By:
- Publication type:
- Article
Correction: Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Retraction Note: The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01504-7
- By:
- Publication type:
- Article
CRISPR screening in hematology research: from bulk to single-cell level.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01495-5
- By:
- Publication type:
- Article
Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01503-8
- By:
- Publication type:
- Article
Correction: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01500-x
- By:
- Publication type:
- Article
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01498-2
- By:
- Publication type:
- Article
CT041 CAR T cell therapy for Claudin18.2-positive metastatic pancreatic cancer.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01499-1
- By:
- Publication type:
- Article
Recent advances in targeted strategies for triple-negative breast cancer.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01497-3
- By:
- Publication type:
- Article
Beyond Bruton's tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody–drug conjugates, CAR T-cells, and novel agents.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01496-4
- By:
- Publication type:
- Article
Advances in single-cell RNA sequencing and its applications in cancer research.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01494-6
- By:
- Publication type:
- Article
Challenges and new technologies in adoptive cell therapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01492-8
- By:
- Publication type:
- Article
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01490-w
- By:
- Publication type:
- Article
Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01487-5
- By:
- Publication type:
- Article
New immunotherapy strategies for patients with sarcomas: highlights from the 2023 ASCO annual meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01486-6
- By:
- Publication type:
- Article
Bispecific antibodies targeting BCMA, GPRC5D, and FcRH5 for multiple myeloma therapy: latest updates from ASCO 2023 Annual Meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01489-3
- By:
- Publication type:
- Article
CD20 × CD3 bispecific antibodies for lymphoma therapy: latest updates from ASCO 2023 annual meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01488-4
- By:
- Publication type:
- Article